{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T16:43:09Z","timestamp":1719938589441},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pupt.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T22:17:53Z","timestamp":1443219473000},"page":"17-18","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cutaneous hypersensitivity and eosinophilia associated with treprostinil"],"prefix":"10.1016","volume":"35","author":[{"given":"Aparna","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameep","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin B.","family":"Highland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12 Suppl. S","key":"10.1016\/j.pupt.2015.09.006_bib0010","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol"},{"issue":"5","key":"10.1016\/j.pupt.2015.09.006_bib0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.pupt.2015.09.006_bib0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaad.2003.12.032","article-title":"Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy","volume":"51","author":"Myers","year":"2004","journal-title":"J. Am. Acad. Dermatol"},{"issue":"1","key":"10.1016\/j.pupt.2015.09.006_bib0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1378\/chest.122.1.378","article-title":"Severe erythroderma as a complication of continuous epoprostenol therapy","volume":"122","author":"Ahearn","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pupt.2015.09.006_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archderm.142.2.155","article-title":"Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis","volume":"142","author":"Bahrami","year":"2006","journal-title":"Arch. Dermatol"},{"issue":"10","key":"10.1016\/j.pupt.2015.09.006_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/thx.2009.116111","article-title":"Iloprost-induced rash","volume":"64","author":"Finn","year":"2009","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pupt.2015.09.006_bib0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.112.124388","article-title":"Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial","volume":"127","author":"Jing","year":"2013","journal-title":"Circulation"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T02:03:36Z","timestamp":1537322616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553915001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":7,"alternative-id":["S1094553915001017"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2015.09.006","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous hypersensitivity and eosinophilia associated with treprostinil","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}